Pediatric Hematology/Oncology : Clinical Services

Hemophilia Treatment Center

The Hemophilia Treatment Center (HTC) at the University of Miami serves all ages – from birth through adulthood. Dr Joanna Davis is the Medical Director of the Pediatric HTC. Dr. Fernando-Corrales-Medina is the Associate Director of the Pediatric HTC. Krysten Sargenton, ARNP, is the Nurse Coordinator for the Pediatric HTC. Dr. Thomas Harrington is the Medical Director of the Adult HTC; Maya Bloomberg, ARNP, is the Nurse Coordinator of the Adult HTC. Annalise Guerra is the HTC Social Worker and licensed therapist. Samantha Gupta, DPT, is the dedicated physical therapist. Leandro Pisani is the HTC Clinical Research Coordinator. Maggie Gonzalez is the Office Administrator and 340B program manager. Merissa Williams is the HTC Outreach Coordinator.

The HTC is the only federally -funded 501c (3) non-profit program in South Florida, and offers state-of-the-art comprehensive care to all persons living with a bleeding or clotting disorder. This includes the hemophilias, von Willebrand’s disease, rare bleeding disorders, platelet disorders, inherited and acquired hypercoagulable disorders. The University of Miami has a reference Special Coagulation Laboratory on site, allowing our patients the ability to have thorough coagulation evaluations in a timely manner. Oversight of surgical procedures ensures maximum safety and minimal risk of unusual bleeding. We are available for diagnostic consultations as well as co-management for surgeries or deliveries/post-partum issues that occur in the community. The HTC is dedicated to the challenges facing women with bleeding disorders, as well as the risks to potentially affected infants in the immediate newborn period.

A monthly Pediatric Clinic is held at the UHealth facility in Plantation, to allow patients who live at a distance the opportunity for greater ease of scheduling appointments.

A Mission Statement of the HTC is the dedication to outreach and education for both medical and patient communities. The HTC has received educational grants from the Hemophilia Foundation of Greater Florida to support a practical and informative lecture covering the current management of the hemophilias. This has been presented at hospitals across the country. The HTC staff also offers educational sessions covering women’s issues and excessive clotting (VTE).

Research is another focus of the HTC. We participate in numerous protocols studying new therapies, and are currently enrolling patients on 3 investigator -sponsored ultrasound studies for toddlers, women and older children.

A 340B factor program is available for eligible patients.
Our Social Worker provides current information and assistance pertaining to available insurance options for our families.

We believe that the best patient care results from understanding and cooperation between patient/family, primary care physicians, and HTC staff.